$PHR

Hui Yvonne sold $15K of PHR

Hui Yvonne (Principal Accounting Officer) sold 1,371 shares of Phreesia, Inc. (PHR) at $10.84 on 2026-07-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Hui Yvonne
Published Jul 7, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 7:59 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PHR
Neutral
high confidence
Mentioned
$PHR
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PHRNeutralLow
01

Why it matters

The disclosure updates the record of insider trading activity but does not introduce new operational, financial, or regulatory information about Phreesia.

02

Market read

Traders may note the insider sale, but the pre-arranged 10b5-1 context makes it unlikely to drive a durable repricing by itself.

03

What to watch

The article provides only the sale details; it does not include any concurrent buys, guidance changes, or material company events that would strengthen a trading thesis.

Relevance 2/10Novelty 2/10Timing: filed 2026-07-07, sale executed 2026-07-06

Background

This is an SEC Form 4 insider transaction disclosure for Phreesia, Inc. (PHR).

Company-level read

Ticker impact

$PHRNeutralHigh confidence
Context

Phreesia Form 4 shows insider Hui Yvonne sold 1,371 shares at $10.84 on 2026-07-06 under a 10b5-1 plan.

Expected impact

Low near-term impact; any reaction is likely muted unless accompanied by other disclosures.

Evidence & confidence

The filing is a scheduled open-market sale by an accounting officer with a pre-arranged 10b5-1 plan, and no new company-specific operational or financial information is disclosed.

Market effects

No clear sector read-through from a single routine insider sale.

None indicated.

None indicated.

Counterpoint

Insider sales can still reflect private liquidity needs or risk management, but the 10b5-1 designation reduces interpretability.

Key entities

  • Phreesia, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Hui Yvonne

    Principal Accounting Officer who executed an open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PHRMed

Phreesia’s (PHR) Profit Turnaround Meets A Cash-Strapped Client Base

Phreesia (PHR) reported Q2 2027 revenue of $129.5M and adjusted EBITDA of $32.9M, marking five straight quarters of positive net income. Revenue grew 10% YoY, with client count and revenue per client also increasing. The company reduced debt by $23M and credited AI for operational efficiencies. However, management warned of increased unpredictability in network solutions revenue due to financial strain on healthcare providers. Phreesia reaffirmed its full-year revenue and EBITDA guidance.

$PHRHighAI 8/10

Phreesia (PHR) Q2 2027 Earnings Call Transcript

Phreesia (PHR) reported Q2 2027 revenue of $129.5M, up 10% YoY, with adjusted EBITDA of $32.9M and net income of $1.9M. AHSCs grew 6% to 4,744. Full-year guidance: revenue $510M-$520M, adjusted EBITDA $125M-$135M. Management noted variability in revenue forecasting and economic pressures on healthcare providers.

$PHRMed

Why Phreesia Stock Got Knocked Down Today

Phreesia (PHR) stock fell 7% Tuesday due to bearish sentiment after Q2 earnings and a downgrade by Raymond James analyst John Ransom. Ransom cited declining organic revenue growth and AI spending pressures. Despite a 10% revenue increase, concerns remain about future performance and market constraints.

$PHRMed

Why Phreesia Stock Tumbled Today

Phreesia (PHR) shares fell 6.33% after reporting Q2 2027 revenue of $129.5M, up 10% YoY, and GAAP net income of $1.9M. While revenue beat estimates, earnings per share missed expectations. The company maintained full-year guidance and highlighted recent product launches.

$PHRLow

Phreesia Announces Second Quarter Fiscal 2027 Results

Phreesia, Inc. (PHR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Phreesia Announces Second Quarter Fiscal 2027 Results ALL-REMOTE COMPANY/WILMINGTON, Del., September 2, 2026 – Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2026. “Phreesia deli